Table: Zeria Pharm - 6-MTH group results

Zeria Pharmaceutical

02/11/2022 07:00

Nov 2 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             33.71               28.61            66.00    
                 (+17.9 pct)         (+12.1 pct)      (+10.9 pct) 
  Operating          5.89                2.67             7.00    
                (+120.6 pct)         (+67.2 pct)      (+10.0 pct) 
  Recurring          5.18                3.12             7.00    
                 (+66.3 pct)        (+138.4 pct)      (+17.9 pct) 
  Net                4.00                2.12             5.60    
                 (+89.0 pct)         (+52.4 pct)      (+41.4 pct) 
  EPS             90.41 yen           46.65 yen       126.73 yen  
  Ann Div                             35.00 yen        36.00 yen  
  -Q2 div         18.00 yen           17.00 yen                   
  -Q4 div                             18.00 yen        18.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T